A.I. BURNASYAN FMBC CLINICAL BULLETIN

ISSN 2782-6430 (print)

State Research Center −Burnasyan Federal Medical Biophysical
Center of Federal Medical Biological Agency

The journal is published in Russian.
Format – A4.
The periodicity of the journal is 4 times a year.

Issue №2 2025 год

A.I. Burnasyan  FMBC clinical bulletin. 2025 № 1

S.G. Burd1,2, A.V. Lebedeva1,2,3, Yu.V. Rubleva1, A.P. Efimenko1 , T.A. Bokitko1 ,
N.V. Pantina1, A.V. Yurchenko1,
M.A. Bogomazova1, I.I. Kovaleva1, G.A. Alekseeva1

Clinical and Diagnostic Criteria for Creutzfeldt-Jakob Disease. Clinical Observation

1Federal center of brain research and neurotechnologies of Federal Medical Biological Agency, Moscow, Russia

2Pirogov Russian National Research Medical University, Moscow, Russia

3Research Institute of Health Care Organization and Medical Management of the Moscow City Health Department, Moscow, Russia

Contact person: Efimenko A.P.: efimenko2296@mail.ru

Abstract
Subject, theme, purpose of the work: one of the most common prion diseases in humans is Creutzfeldt-Jakob disease (CJD). According to the literature, the prevalence of Creutzfeldt-Jakob disease in the world is 1-2 cases per 1 million population, however, interest in this disease is steadily growing. There is currently no effective treatment for Creutzfeldt-Jakob disease. The purpose of the work is to highlight the clinical and diagnostic criteria of this rare prion disease to increase awareness among doctors, early detection, search for new diagnostic methods, prevention options and treatment of this disease.
Method or methodology of the work: literature review of clinical and diagnostic criteria of Creutzfeldt-Jakob disease, including foreign sources and clinical guidelines. The article presents an analysis of our own clinical observation of a patient with Creutzfeldt-Jakob disease with a characteristic symptom complex, interpretation of examination results (MRI, EEG) and justification of the diagnosis.
Results of the work: systematization of clinical and diagnostic criteria of Creutzfeldt-Jakob disease with adaptation for use in routine clinical practice.
Scope of application of the results: clinical practice of a neurologist, psychiatrist, therapist, resuscitator, functional diagnostics doctor and radiologist.
Conclusions: prion encephalopathies, due to their rare occurrence and insufficient awareness of doctors, are often hidden under the guise of various neurodegenerative, vascular, autoimmune, infectious and mental diseases. Timely verification of the diagnosis of Creutzfeldt-Jakob disease allows to exclude potentially curable neurodegenerative diseases, determine the tactics of patient management and prognosis. Currently, diagnostic criteria have been developed that allow to assume the diagnosis of Creutzfeldt-Jakob disease in a patient with rapidly progressing dementia, based on the clinical picture, MRI and EEG data, without the use of rare specific diagnostic methods. This article presents a description of our own observation of a patient with probable Creutzfeldt-Jakob disease.

Keywords: prion diseases, prion, encephalopathy, rapidly progressive dementia, triphasic waves, neurodegenerative  diseases, Creutzfeldt-Jakob disease, electroencephalography, diagnostic criteria

For citation: Burd SG, Lebedeva, AV. Rubleva YuV, Efimenko AP, Bokitko TA, Pantina NV, Yurchenko AV, Bogomazova MA, Kovaleva II, Alekseeva GA. Clinical and Diagnostic Criteria for Creutzfeldt-Jakob Disease. Clinical ObservationA.I. Burnasyan Federal Medical Biophysical Center Clinical Bulletin. 2025.1:29-34. (In Russian) DOI: 10.33266/2782-6430-2025-1-29-34

 

REFERENCES

  1. Ершова А.А., Котов А.С. Болезнь Крейтцфельдта–Якоба: описание трех клинических случаев // Неврологический журнал им. Л.О Бадаляна. 2022. Т.3. №1. С. 42-48 [Yershova A.A, Kotov A.S. Creutzfeldt–Jakob Disease: Description of Three Clinical Cases. Nevrologicheskiy Zhurnal im. L.O. Badalyana = Neurological Journal named after L.O. Badalyan. 2022;3;1:42-48 (In Russ.)]. doi.org/10.46563/2686-8997-2022-3-1-42-48
  2. Imran M., Mahmood S. An Overview of Human Prion Diseases. Virol J. 2011 Dec 24;8:559. doi: 10.1186/1743-422X-8-559. PMID: 22196171;
  3. Заваденко Н.Н., Хондкарян Г.Ш., Бембеева Р.Ц., Холин А.А., Саверская Е.Н. Прионные заболевания человека: современные аспекты // Журнал неврологии и психиатрии им. С.С. Корсакова. 2018. Т.18. №6. С. 88-95 [Zavadenko N.N., Khondkaryan G.SH., Bembeyeva R.Ts., Kholin A.A., Saverskaya Ye.N. Human Prion Diseases: Modern Aspects. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova = Journal of Neurology and Psychiatry named after S.S. Korsakov. 2018;18;6:88-95 (In Russ.)]. doi.org/10.17116/jnevro20181186188
  4. Wille H., Requena J.R. The Structure of PrPSc Prions. Pathogens. 2018 Feb 7;7;1:20. doi: 10.3390/pathogens7010020. PMID: 29414853
  5. Feng S., Zhao X., Zhou X., Ye X., Yu X., Jiang W., Deng Y., Zhou S., Ma L., Shan P., Zhou G. Epidemiological and Clinical Characteristics of Sporadic Creutzfeldt-Jakob Disease: a Retrospective Study in Eastern China. Front Neurol. 2021 Oct 6;12:700485. doi: 10.3389/fneur.2021.700485. PMID: 34690910
  6. Попова Т.Е., Таппахов А.А., Давыдова Т.К., Николаева Т.Я., Хабарова Ю.И., Варламова М.А., Оконешникова Л.Т. Болезнь Крейтцфельда-Якоба в Республике Саха (Якутия) // Неврология, нейропсихиатрия, психосоматика. 2020. Т.12. №2. С. 86-91 [Popova T.E., Tappakhov A.A., Davydova T.K., Nikolaeva T.Ya., Khabarova Yu.I., Varlamova M.A., Okoneshnikova L.T. Creutzfeldt-Jakob Disease in the Republic of Sakha (Yakutia). Nevrologiya, Neyropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12;2:86-91 (In Russ.)]. doi.org/10.14412/2074-2711-2020-2-86-91.
  7. Uttley L., Carroll C., Wong R., Hilton D.A., Stevenson M. Creutzfeldt-Jakob Disease: a Systematic Review of Global Incidence, Prevalence, Infectivity, and Incubation. Lancet Infect Dis. 2020 Jan;20;1:e2-e10. doi: 10.1016/S1473-3099(19)30615-2. PMID: 31876504.
  8. Brownell B., Oppenheimer D.R. An Ataxic Form of Subacute Presenile Polioencephalopathy (Creutzfeldt-Jakob Disease). J Neurol Neurosurg Psychiatry. 1965 Aug;28;4:350-61. doi: 10.1136/jnnp.28.4.350. PMID: 14338125.
  9. Heidenhain A. Klinische und Anatomische Untersuchungen Über Eine Eigenartige Organische Erkrankung des Zentralnervensystems im Praesenium. Z Für Gesamte Neurol Psychiatr. 1929;118;1:49-114.
  10. Wall C.A., Rummans T.A., Aksamit A.J., Krahn L.E., Pankratz V.S. Psychiatric Manifestations of Creutzfeldt-Jakob Disease: a 25-year Analysis. J Neuropsychiatry Clin Neurosci. 2005 Fall;17;4:489-95. doi: 10.1176/jnp.17.4.489. PMID: 16387988.
  11. Krasnianski A., Bohling G.T., Harden M., Zerr I. Psychiatric Symptoms in Patients with Sporadic Creutzfeldt-Jakob Disease in Germany. J Clin Psychiatry. 2015 Sep;76;9:1209-15. doi: 10.4088/JCP.13m08915. PMID: 25938948.
  12. Fernández-Torre J.L. Nonconvulsive Status Epilepticus in Creutzfeldt-Jakob Disease. Clin Neurophysiol. 2006 Aug;117;8:1879-80; author reply 1881. doi: 10.1016/j.clinph.2006.04.023. Epub 2006 Jun 27. PMID: 16807098.
  13. Kang P., de Bruin G.S., Wang L.H., Ward B.A., Ances B.M., Lim M.M., Bucelli R.C. Sleep Pathology in Creutzfeldt-Jakob Disease. J Clin Sleep Med. 2016 Jul 15;12;7:1033-9. doi: 10.5664/jcsm.5944. PMID: 27250807
  14. Kobylecki C., Thompson J.C., Jones M., Mills S.J., Shaunak S., Ironside J.W., Snowden J.S., Richardson A.M. Sporadic Creutzfeldt-Jakob Disease Presenting as Progressive Nonfluent Aphasia with Speech Apraxia. Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27;4:384-6. doi: 10.1097/WAD.0b013e318260ab27. PMID: 22732678.
  15. Pedersen N.S., Smith E. Prion Diseases: Epidemiology in Man. APMIS. 2002 Jan;110;1:14-22. doi: 10.1034/j.1600-0463.2002.100103.x. PMID: 12064251.
  16. Sikorska B., Knight R., Ironside J.W., Liberski P.P. Creutzfeldt-Jakob Disease. Adv Exp Med Biol. 2012;724:76-90. doi: 10.1007/978-1-4614-0653-2_6. PMID: 22411235.
  17. Duffy P., Wolf J., Collins G., DeVoe A.G., Streeten B., Cowen D. Letter: Possible Person-to-Person Transmission of Creutzfeldt-Jakob Disease. N Engl J Med. 1974 Mar 21;290;12:692-3. PMID: 4591849.
  18. Kurne A., Ertuğrul A., Anil Yağcioğlu A.E., Demirci E., Yazici K.M., Kansu T. Creutzfeldt-Jakob Disease: a Case that Initiated with Psychiatric Symptoms. Turk Psikiyatri Derg. 2005 Spring;16;1:55-9. PMID: 15793699.
  19. Hermann P., Appleby B., Brandel J.P., Caughey B., Collins S., Geschwind M.D., Green A., Haïk S., Kovacs G.G., Ladogana A., Llorens F., Mead S., Nishida N., Pal S., Parchi P., Pocchiari M., Satoh K., Zanusso G., Zerr I. Biomarkers and Diagnostic Guidelines for Sporadic Creutzfeldt-Jakob Disease. Lancet Neurol. 2021 Mar;20;3:235-246. doi: 10.1016/S1474-4422(20)30477-4. PMID: 33609480.
  20. WHO G. Global surveillance, Diagnosis and Therapy of Human Transmissible Spongiform Encephalopathies. Report of a WHO Consultation. Geneva, Switzerland 9-11 February 1998. Published online 1998.
  21. Zerr I., Kallenberg K., Summers D.M., Romero C., Taratuto A., Heinemann U., Breithaupt M., Varges D., Meissner B., Ladogana A., Schuur M., Haik S., Collins S.J., Jansen G.H., Stokin G.B., Pimentel J., Hewer E., Collie D., Smith P., Roberts H., Brandel J.P., van Duijn C., Pocchiari M., Begue C., Cras P., Will R.G., Sanchez-Juan P. Updated Clinical Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease. Brain. 2009 Oct;132;Pt 10:2659-68. doi: 10.1093/brain/awp191. PMID: 19773352;
  22. Wieser H.G., Schindler K., Zumsteg D. EEG in Creutzfeldt-Jakob Disease. Clin Neurophysiol. 2006 May;117;5:935-51. doi: 10.1016/j.clinph.2005.12.007. PMID: 16442343.
  23. Брутян А.Г, Корепина О.С, Абрамова А.А., Белякова-Бодина А.И. Роль электроэнцефалографии в диагностике болезни Крейтцфельдта-Якоба // Нервные болезни. 2019. №4. С. 24-31 [Brutyan A.G, Korepina O.S, Abramova A.A., Belyakova-Bodina A.I. The Role of Electroencephalography in the Diagnosis of Creutzfeldt-Jakob Disease. Nervnyye Bolezni = Nervous Diseases. 2019;4:24-31 (In Russ.)].
  24. Neufeld M.Y., Korczyn A.D. Topographic Distribution of the Periodic Discharges in Creutzfeldt-Jakob Disease (CJD). Brain Topogr. 1992 Spring;4;3:201-6. doi: 10.1007/BF01131151. PMID: 1633058.

Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 21.11.2024. Accepted for publication: 19.12.2024

Scroll to Top